Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress replacement systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Perfecto2, Perfecto2 V, and Platinum brands; Invacare HomeFill oxygen systems; and Invacare SOLO2 and XPO2 transportable oxygen concentrators. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:IVC
CUSIP46120310
Phone440-329-6000
Debt
Debt-to-Equity Ratio0.64
Current Ratio2.10
Quick Ratio1.41
Price-To-Earnings
Trailing P/E Ratio-7.64
Forward P/E Ratio-11.52
P/E GrowthN/A
Sales & Book Value
Annual Sales$966.50 million
Price / Sales0.51
Cash FlowN/A
Price / CashN/A
Book Value$10.80 per share
Price / Book1.37
Profitability
EPS (Most Recent Fiscal Year)($1.93)
Net Income$-76,540,000.00
Net Margins-6.80%
Return on Equity-12.52%
Return on Assets-4.95%
Miscellaneous
Employees4,200
Outstanding Shares33,240,000
Market Cap$500.19 million
Invacare (NYSE:IVC) Frequently Asked Questions
What is Invacare's stock symbol?
Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."
How often does Invacare pay dividends? What is the dividend yield for Invacare?
Invacare declared a quarterly dividend on Thursday, August 30th. Stockholders of record on Friday, October 12th will be given a dividend of $0.0125 per share on Friday, October 26th. This represents a $0.05 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Thursday, October 11th. View Invacare's Dividend History.
How were Invacare's earnings last quarter?
Invacare Co. (NYSE:IVC) posted its quarterly earnings data on Tuesday, August, 7th. The health services provider reported ($0.41) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.30) by $0.11. The health services provider had revenue of $246.15 million for the quarter, compared to analyst estimates of $247.90 million. Invacare had a negative return on equity of 12.52% and a negative net margin of 6.80%. View Invacare's Earnings History.
When is Invacare's next earnings date?
What price target have analysts set for IVC?
2 equities research analysts have issued 1 year price objectives for Invacare's shares. Their forecasts range from $23.00 to $23.00. On average, they anticipate Invacare's share price to reach $23.00 in the next twelve months. This suggests a possible upside of 55.9% from the stock's current price. View Analyst Price Targets for Invacare.
What is the consensus analysts' recommendation for Invacare?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Invacare.
Who are some of Invacare's key competitors?
Some companies that are related to Invacare include CONSORT Med PLC/S (CSRMY), Sientra (SIEN), Establishment Labs (ESTA), RTI Surgical (RTIX), Lakeland Industries (LAKE), ConforMIS (CFMS), Rewalk Robotics (RWLK), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX), NanoVibronix (NAOV), Bionik Laboratories (BNKL), Precision Therapeutics (AIPT), Allied Healthcare Products (AHPI) and Avitar (AVTI).
Who are Invacare's key executives?
Invacare's management team includes the folowing people:
- Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 50)
- Ms. Kathleen P. Leneghan, Sr. VP & CFO (Age 55)
- Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel & Sec. (Age 60)
- Mr. Dean J. Childers, Sr. VP & GM of North America (Age 51)
- Mr. Ralf Ledda, Sr. VP & GM of EMEA (Age 50)
Who are Invacare's major shareholders?
Invacare's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.98%), Waddell & Reed Financial Inc. (5.70%), Royce & Associates LP (4.79%), Millennium Management LLC (4.19%), Dalton Greiner Hartman Maher & Co. (2.07%) and Granahan Investment Management Inc. MA (2.14%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, C Martin Harris, Dale C Laporte, Dean J Childers and Matthew E Monaghan. View Institutional Ownership Trends for Invacare.
Which major investors are selling Invacare stock?
IVC stock was sold by a variety of institutional investors in the last quarter, including Waddell & Reed Financial Inc., Northpointe Capital LLC, Brandes Investment Partners LP, Millennium Management LLC, Point72 Asset Management L.P., California Public Employees Retirement System, Engineers Gate Manager LP and Bank of Nova Scotia. Company insiders that have sold Invacare company stock in the last year include Anthony Laplaca, Baiju R Shah, C Martin Harris and Dean J Childers. View Insider Buying and Selling for Invacare.
Which major investors are buying Invacare stock?
IVC stock was bought by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., BlackRock Inc., Cortina Asset Management LLC, Spark Investment Management LLC, Renaissance Technologies LLC, Wells Fargo & Company MN, Granahan Investment Management Inc. MA and Royce & Associates LP. Company insiders that have bought Invacare stock in the last two years include Baiju R Shah and Matthew E Monaghan. View Insider Buying and Selling for Invacare.
How do I buy shares of Invacare?
Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Invacare's stock price today?
One share of IVC stock can currently be purchased for approximately $14.75.
How big of a company is Invacare?
Invacare has a market capitalization of $500.19 million and generates $966.50 million in revenue each year. The health services provider earns $-76,540,000.00 in net income (profit) each year or ($1.93) on an earnings per share basis. Invacare employs 4,200 workers across the globe.
What is Invacare's official website?
How can I contact Invacare?
Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44035. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected]
MarketBeat Community Rating for Invacare (NYSE IVC)
MarketBeat's community ratings are surveys of what our community members think about Invacare and other stocks. Vote "Outperform" if you believe IVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVC will underperform the S&P 500 over the long term. You may vote once every thirty days.
